Delivery Order SPE2DB20D2104-SPE2DB24FT30H
- Not listed
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Mupirocin 2% Cream, a topical antibiotic medication, with a ceiling value of $1,153.70 and a period of performance through May 10, 2023. The contract is a Firm Fixed Price agreement and does not have a set-aside designation, indicating open competition. AmerisourceBergen, a Fortune 500 company, is a...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,362.14, is for the delivery of mupirocin 2% ointment, a topical antibiotic medication. The order has a firm fixed price and an ultimate completion date of August 16, 2023. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Mupirocin 2% cream in 15-gram units. The single-award, firm-fixed-price contract has a ceiling value of $4,981.13 and runs through January 27, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999, which serves as a primary vehicle for providing a comprehensive...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The order is for the supply of mupirocin 2% cream, a topical antibiotic medication, with a ceiling value of $1,067.80 and a period of performance through August 2024. Amerisourcebergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical and the Department of Justice Federal Bureau of...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Mupirocin 2% Cream in 15 gram quantities, with a ceiling value of $1,647.18 and a delivery period ending on March 26, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Mupirocin 2% Cream 30GM, a topical antibiotic medication. The contract has a ceiling value of $2,911.12 and a performance period through May 29, 2025. It is a firm-fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a for-profit pharmaceutical distribution company. The contract, valued at $1,851.13, is for the supply of Mupirocin 2% Cream, a topical antibiotic medication, to support military and federal healthcare programs. The contract has an ultimate completion date of January 18, 2024. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Mupirocin 2% Cream 30 GM. The delivery order has a ceiling value of $3,736.91 and is a firm fixed-price contract type. The ultimate completion date for this order is August 13, 2024. This delivery order falls under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Mupirocin 2% Ointment, a prescription topical antibiotic. The contract has a ceiling value of $1,030.32 and a completion date of August 30, 2024. It is a firm-fixed-price contract, with no set-aside designation indicated. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,024.18, is for the delivery of Mupirocin 2% Cream 15gm, a topical antibiotic medication. The contract has a firm fixed price pricing type and an ultimate completion date of June 10, 2024. The contract is not designated with a set-aside requirement, indicating open competition....
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB24FT30HDelivery Order
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Mupirocin 2% cream, a topical antibiotic medication, with a ceiling value of $1,055.59 and a performance period through March 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific delivery order does not have a set-aside designation, indicating open competition. AmerisourceBergen's extensive federal contract portfolio and role as a critical supplier of medical commodities to the U.S. government, particularly the Department of Defense and Veterans Affairs, demonstrate the company's significance as a key vendor for federal healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 3/28/24 |